Abingworth LLP Vera Therapeutics, Inc. Call Options Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VERA
# of Institutions
183Shares Held
54.8MCall Options Held
42.2KPut Options Held
121K-
Avoro Capital Advisors LLC New York, NY4.31MShares$204 Million2.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.62MShares$171 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$158 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$132 Million5.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$119 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.28B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...